Advancing evidence-generating medicine
Osmind’s research is helping to set new standards for mental health interventions and improve patient outcomes. See how we work with research partners to generate real-world evidence to accelerate advances in mental health care.
![Doctor treating patient at his office](https://cdn.prod.website-files.com/65c1358b4dec382d8356a688/6631184f9c46424f4ea9272a_KSP04147.webp)
![](https://cdn.prod.website-files.com/65c1358b4dec382d8356a688/65c4d9d29866ee4377e4bd6d_research-path.webp)
Selected research projects
Osmind Welcomes Former Global Head of Neuroscience at J&J, Husseini Manji, MD, as a Strategic Advisor
Successful dTMS in rTMS, ECT, and Ketamine Refractory Depression: A Case Series
Aslam, Handoo, MacMillan, Muir (2024). Clinical TMS Society Annual Meeting.
Utilizing nVNS Treatment Effectively After Non-Response to Accelerated H7 and H1 Treatment in Highly Refractory Depression: A Case Report
Aslam, MacMillan, Muir (2024) Clinical TMS Society Annual Meeting.
Peril and Promise: Teens, Tech, and America’s Mental Health Crisis
Belfort, MacMillan, Weigle (2024). Child and Adolescent Psychiatric Clinics of North America.
Comparative Effectiveness of Ketamine Intravenous Therapy and Intranasal Esketamine for Depression in Real-world Settings
McInnes and Kane (2024). American Society of Clinical Psychopharmacology Annual Meeting.
A retrospective study of real-world outcomes for esketamine nasal spray among patients with treatment resistant depression
McInnes, Joshi, Kane, et al. (2024). American Society of Clinical Psychopharmacology Annual Meeting.
Let's transform mental health together
Click here to learn more about our research or to discuss collaboration opportunities.
![Company team chatting at an informal reunion](https://cdn.prod.website-files.com/65c1358b4dec382d8356a688/65c64d2f69ca49ec6add9bc6_research-KSP.webp)
![](https://cdn.prod.website-files.com/65c1358b4dec382d8356a688/65c4d9d29866ee4377e4bd6d_research-path.webp)